Pseudophakic Bullous Keratopathy Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting pseudophakic bullous keratopathy clinical trials across 8 countries. Studies span Not Applicable, Phase 1, Phase 3, Phase 4. Top locations include Apeldoorn, Gelderland, Netherlands, Atlanta, Georgia, United States, Bonheiden, Belgium. Updated daily from ClinicalTrials.gov.


Pseudophakic Bullous Keratopathy Trials at a Glance

8 actively recruiting trials for pseudophakic bullous keratopathy are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Apeldoorn, Atlanta, and Bonheiden. Lead sponsors running pseudophakic bullous keratopathy studies include Aurion Biotech, Centre Hospitalier Régional Metz-Thionville, and Asociación para Evitar la Ceguera en México.

Browse pseudophakic bullous keratopathy trials by phase

About Pseudophakic Bullous Keratopathy Clinical Trials

Looking for clinical trials for Pseudophakic Bullous Keratopathy? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pseudophakic Bullous Keratopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pseudophakic Bullous Keratopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Corneal EdemaCorneal Endothelial DysfunctionFuchs Endothelial Corneal Dysfunction+1 more
Aurion Biotech120 enrolled12 locationsNCT07368959
Recruiting
Not Applicable

The Belgian Endothelial Surgical Transplant of the Cornea

Pseudophakic Bullous KeratopathyFuchs' Endothelial DystrophyCorneal Edema+2 more
University Hospital, Antwerp220 enrolled11 locationsNCT05436665
Recruiting
Phase 1

PVEK Corneal Implant For Treatment of Corneal Edema

Pseudophakic Bullous KeratopathyFuchs' Endothelial DystrophyCorneal Edema+1 more
Precise Bio15 enrolled3 locationsNCT07325097
Recruiting
Phase 1

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Endothelial DysfunctionPseudophakic Bullous KeratopathyFuchs' Endothelial Dystrophy+5 more
Asociación para Evitar la Ceguera en México12 enrolled1 locationNCT05636579
Recruiting
Phase 4

The OPTIMISE Study

Intraocular PressurePseudophakic Bullous KeratopathyFuchs' Endothelial Dystrophy
Maastricht University Medical Center342 enrolled8 locationsNCT05716945
Recruiting

OCT in Fuchs' Dystrophy

Pseudophakic Bullous KeratopathyFuchs Dystrophy
Oregon Health and Science University60 enrolled1 locationNCT04258787
Recruiting

Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study

Pseudophakic Bullous KeratopathyFuchs' Endothelial Corneal Dystrophy
Centre Hospitalier Régional Metz-Thionville1,000 enrolled1 locationNCT06859411
Recruiting
Not Applicable

Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK

Pseudophakic Bullous KeratopathyFuchs' Endothelial Dystrophy
Dar El Oyoun Hospital15 enrolled1 locationNCT06652321